Search Results - Neil Rabin
- Showing 1 - 14 results of 14
-
1
-
2
PERCEPT myeloma: a protocol for a pilot randomised controlled trial of exercise prehabilitation before and during autologous stem cell transplantation in patients with multiple mye... by Gita Ramdharry, Orla McCourt, Abigail Fisher, Anna L Roberts, Joanne Land, Neil Rabin, Kwee Yong
Published in BMJ Open (2020-01-01)Get full text
Article -
3
-
4
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers by Gordon Cook, John Ashcroft, John Ashcroft, Mariana Fernandez, Sarah Henshaw, Zeyad Khalaf, Guy Pratt, Anish Tailor, Neil Rabin
Published in Frontiers in Oncology (2023-02-01)Get full text
Article -
5
Real-world evaluation of physiotherapist-led exercise prehabilitation and rehabilitation during autologous stem cell transplantation in myeloma: a single-centre experience by Orla McCourt, Joanne Land, Neil Rabin, Kwee Yong, Abi Fisher, Jonathan Sive, Charalampia Kyriakou, Michael K Luong, Alasdair Longden
Published in BMJ Open Quality (2025-01-01)Get full text
Article -
6
Myeloid neoplasm post cytotoxic treatment in patients with multiple myeloma by Ke Xu, Eleanor Kaffo, Robert Baker, Elisabeth Nacheva, Annabel McMillan, Lydia Lee, Xenofon Papanikolaou, Rakesh Popat, Jonathan Sive, Kwee Yong, Neil Rabin, Charalampia Kyriakou, Rajeev Gupta
Published in eJHaem (2024-10-01)Get full text
Article -
7
Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single center, real-world experience by Ke Xu, Charles Agbuduwe, Nickolaos Kanellias, William Wilson, Annabel McMillan, Xenofon Papanikolaou, Lydia Lee, Rakesh Popat, Jonathan Sive, Neil Rabin, Kwee Yong, Agapi Parcharidou, Charalampia Kyriakou
Published in Haematologica (2024-12-01)Get full text
Article -
8
PB2108: SPINAL INVOLVEMENT IS ASSOCIATED WITH HIGH INCIDENCE OF SKELETAL RELATED EVENTS AND INFERIOR OVERALL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA. A SINGLE CENTRE EXPERIENCE... by Nikolaos Kanellias, Agapi Parcharidou, Ke Xu, Rodothea Americanou, Adam Benton, Sean Molloy, Jan Herzog, Rigin Hargunani, Kwee Yong, Rakesh Popat, Jonathan Sive, Lydia Lee, Annabel Mcmilan, Xenofon Papanikolaou, Neil Rabin, Charalampia Kyriakou
Published in HemaSphere (2023-08-01)Get full text
Article -
9
Outcomes of melphalan 140 mg/m2 followed by autologous stem cell transplantation in multiple myeloma patients with co‐morbidities: Single‐centre experience by Dario Melotti, Samir Asher, Ethan Troy‐Barnes, George Nesr, William Wilson, Marquita Camilleri, Rakesh Popat, Ke Xu, Neil Rabin, Jonathan Sive, Xenofon Papanikolaou, Lydia Lee, Annabel McMillan, Kwee Yong, Chara Kyriakou
Published in eJHaem (2024-10-01)Get full text
Article -
10
The Role of Radiotherapy for Patients With Multiple Myeloma in the Modern Era: A Real World Single‐Centre Experience by Dipal Mehta, Maria Gabriel, Nathan Adu‐Poku, Nikolaos Kanellias, Xenofon Papanikolaou, Jonathan Sive, Neil Rabin, Rakesh Popat, Eileen M. Boyle, Lydia Lee, Kwee Yong, Agapi Parcharidou, Suganya Sivabalasingham, Karimali Keshwani, Ke Xu, Charalampia Kyriakou
Published in eJHaem (2025-10-01)Get full text
Article -
11
Under-representation of ethnic minorities in early phase clinical trials for multiple myeloma by Samir Asher, Aikaterini Kazantzi, Fatjon Dekaj, Luke Steventon, Aisha Khatun, Louise Ainley, Annabel McMillan, Neil Rabin, Ashu Wechalekar, Jonathan Sive, Charalampia Kyriakou, Xenofon Papanikolaou, Ke Xu, Shameem Mahmood, Brendan Wisniowski, Lydia Lee, Kwee Yong, Rakesh Popat
Published in Haematologica (2022-08-01)Get full text
Article -
12
PB2091: DISPARITIES IN ENROLMENT INTO MULTIPLE MYELOMA CLINICAL TRIALS BY SOCIOECONOMIC DEPRIVATION by Amrutha Sridhar, Selina Chavda, Hannah Hsu, Hanna Renshaw, Tatianna Fernandes, Catriona Maciter, Samir Asher, Neil Rabin, Jonathan Sive, Charalampia Kyriakou, Xenofon Papanikolaou, Ke Xu, Ashutosh Wechalekar, Shameem Mahmood, Annabel Mcmillan, Lydia Lee, Kwee Yong, Fatjon Dekaj, Rakesh Popat
Published in HemaSphere (2023-08-01)Get full text
Article -
13
High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis by Jahanzaib Khwaja, Joshua Bomsztyk, Shameem Mahmood, Brendan Wisniowski, Raakhee Shah, Anish Tailor, Kwee Yong, Rakesh Popat, Neil Rabin, Charalampia Kyriakou, Jonathan Sive, Simona Degli Esposti, Daniel F. P. Larkin, Sarah Worthington, Alyse Hart, Emma Dowling, Nuno Correia, Ceri Bygrave, Andrzej Rydzewski, Krzysztof Jamroziak, Ashutosh D. Wechalekar
Published in Blood Cancer Journal (2022-09-01)Get full text
Article -
14
Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III... by Roger Owen, John Jones, David Meads, David A Cairns, Christopher Parrish, Gordon Cook, Neil Rabin, Matthew Jenner, Martin Kaiser, Kevin Boyd, Graham Jackson, Catherine Olivier, Amy Beth Coulson, Kara-Louise Royle, Charlotte Pawlyn, Anna Hockaday, Jennifer Bird, Stella Bowcock, Ruth de Tute, Hayley Gardner, Bryony Dawkins, Rowena Henderson, Phillip Best, Bhuvan Kishore, Mark Drayson
Published in BMJ Open (2022-06-01)Get full text
Article
